Estados financieros detallados de PharmaCyte Biotech, Inc. (PMCB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.42, PMCB presenta beneficios negativos (P/E no significativo) y un ROE del -50.84%. La capitalización bursátil es de $4M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $1.2M | $2.0M | $460052 | $301221 | $916249 | $690937 | $468536 | $407431 | $438416 | $391301 |
| Generales y Administrativos | $3.3M | $5.0M | $3.6M | $3.5M | $418145 | $2.2M | $4.8M | $6.1M | $3.9M | $4.9M |
| Gastos Operativos | $4.4M | $7.0M | $4.1M | $3.8M | $3.6M | $4.4M | $6.5M | $8.5M | $4.4M | $6.9M |
| Beneficio Operativo | -$4.4M | -$7.0M | -$4.1M | -$3.8M | -$3.6M | -$4.4M | -$6.5M | -$8.5M | -$4.4M | -$6.9M |
| EBITDA | -$4.4M | -$7.0M | -$4.1M | -$3.8M | -$3.5M | -$4.2M | -$6.5M | -$6.5M | -$4.4M | -$5.3M |
| Gastos por Intereses | $1539 | 0 | 0 | $453 | $3046 | $509 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$4.4M | -$6.8M | -$4.1M | -$3.8M | -$3.6M | -$4.2M | -$4.3M | $333763 | $30.7M | -$19.4M |
| Impuestos | -$4442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$4.4M | -$6.8M | -$4.1M | -$3.8M | -$3.6M | -$4.2M | -$4.3M | $333763 | $30.7M | -$19.4M |
| BPA | $-7.88 | $-10.57 | $-5.55 | $-4.23 | $-2.45 | $-0.27 | $-0.22 | $-1.80 | $3.19 | $-2.77 |
| BPA Diluido | $-15.00 | $-15.00 | $-5.55 | $-4.23 | $-2.45 | $-0.27 | $-0.22 | $-1.80 | $3.19 | $-2.77 |
| Acciones en Circulación (Diluidas) | $563567 | $645793 | $733440 | $903812 | $1.4M | $15.5M | $19.5M | $9.6M | $7.3M | $8.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$1.4M | -$2.1M | -$2.5M | -$1.0M |
| EBITDA | -$1.4M | -$2.1M | -$961828 | -$1.0M |
| Beneficio Neto | -$7.4M | $746860 | -$4.4M | -$5.8M |
| BPA | $-1.24 | $-0.17 | $-0.46 | $-0.54 |
| BPA Diluido | $-1.24 | $-0.17 | $-0.46 | $-0.54 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $3.5M | $1.1M | $515253 | $894861 | $2.2M | $85.4M | $68.0M | $50.2M | $15.2M | $18.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $366316 | $18.5M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $240766 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $3.5M | $1.3M | $653404 | $1.0M | $2.3M | $85.5M | $68.1M | $50.4M | $22.4M | $37.4M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $1.5M | $1.5M | 0 |
| Activos Totales | $8.7M | $6.4M | $5.8M | $6.2M | $7.4M | $90.6M | $73.3M | $59.9M | $55.2M | $46.8M |
| Cuentas por Pagar | $365600 | $352621 | $121885 | $185842 | $172261 | $205361 | $128281 | $389369 | $399204 | $271102 |
| Deuda a Corto | 0 | 0 | 0 | $28918 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $580248 | $644168 | $742851 | $1.0M | $724778 | $704370 | $586581 | $7.4M | $2.9M | $826424 |
| Deuda a Largo | 0 | 0 | 0 | $46282 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $580248 | $644168 | $742851 | $1.1M | $724778 | $704370 | $586581 | $20.4M | $3.3M | $11.8M |
| Reservas | -$89.1M | -$96.0M | -$100.0M | -$103.9M | -$107.4M | -$111.6M | -$116.0M | -$115.6M | -$85.0M | -$104.4M |
| Patrimonio Neto | $8.1M | $5.8M | $5.0M | $5.1M | $6.7M | $89.9M | $72.7M | $39.5M | $51.9M | $33.3M |
| Deuda Total | 0 | 0 | 0 | $75200 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$3.5M | -$1.1M | -$515253 | -$819661 | -$2.2M | -$85.4M | -$68.0M | -$50.2M | -$15.5M | -$37.1M |
| Capital Circulante | $3.0M | $639697 | -$89447 | $6248 | $1.6M | $84.8M | $67.6M | $43.0M | $19.5M | $36.6M |
Balance (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Caja y Equivalentes | $15.4M | $20.2M | $18.6M | $17.7M |
| Activos Totales | $56.0M | $55.9M | $46.8M | $36.7M |
| Pasivos Totales | $19.4M | $16.5M | $11.8M | $6.9M |
| Patrimonio Neto | $36.6M | $39.4M | $33.3M | $29.4M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$4.4M | -$6.8M | -$4.1M | -$3.8M | -$3.6M | -$4.2M | -$4.3M | $333763 | $30.7M | -$19.4M |
| Amortizaciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.0M | $1.5M | $705678 | $748027 | $370829 | $77956 | $645406 | $674693 | $478637 | $1.1M |
| Cambio en Capital Circulante | -$21157 | -$85873 | $167099 | $267349 | -$145608 | $9040 | -$297166 | $298894 | $1.4M | -$1.9M |
| Flujo de Caja Operativo | -$3.3M | -$5.1M | -$2.9M | -$2.3M | -$3.3M | -$4.1M | -$3.8M | -$2.2M | -$3.0M | -$5.2M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$13.6M | -$44.4M | -$25.0M | -$401625 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$246005 |
| Flujo de Caja Libre | -$3.3M | -$5.1M | -$2.9M | -$2.3M | -$3.3M | -$4.1M | -$3.8M | -$2.2M | -$3.0M | -$5.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Flujo de Caja Operativo | -$979523 | -$786848 | -$1.4M | -$780894 |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$979523 | -$786848 | -$1.4M | -$780894 |
| Dividendos Pagados | 0 | 0 | -$246005 | -$83399 |
| Compensación en Acciones | $60492 | $952992 | $54580 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Beneficio Neto (anual) | | -53.7% | +40.4% | +5.9% | +7.2% | -19.4% | -1.8% | +107.7% | +9085.0% | -163.4% |
| Crecimiento BPA (anual) | | -34.1% | +47.5% | +23.8% | +42.1% | +89.0% | +18.5% | -718.2% | +277.2% | -186.8% |
| Cambio en Acciones (anual) | | +14.6% | +13.6% | +23.2% | +60.2% | +971.7% | +25.6% | -50.8% | -23.5% | +14.3% |
| Crecimiento FCF (anual) | | -52.1% | +43.3% | +18.7% | -42.4% | -23.6% | +7.9% | +43.3% | -38.4% | -73.0% |
| Tasa Impositiva Efectiva | 0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | 0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-5.93 | $-7.87 | $-3.92 | $-2.59 | $-2.30 | $-0.27 | $-0.19 | $-0.22 | $-0.41 | $-0.62 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 |
| Acciones en Circulación (Básicas) | $296000 | $455000 | $733000 | $903000 | $1.4M | $15.5M | $19.5M | $185000 | $7.3M | $7.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -50.84% |
| Rentabilidad sobre capital invertido | -14.92% |
| Rentabilidad sobre activos | -41.55% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 45.28 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -2.67 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -14.44 | -7.92 | -11.45 | -8.98 | -11.20 | -8.63 | -13.27 | -1.18 | 0.39 | -0.26 |
| P/VC | 4.16 | 6.60 | 9.24 | 6.74 | 5.95 | 0.40 | 0.78 | 0.01 | 0.18 | 0.15 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |